Moderna’s stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Nasdaq1mon
Decoding Moderna's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 31 unusual trades. Delving into the details, we found 51% of ...
The Globe and Mail21y
the globe and mail
Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly ...
Nasdaq13d
Moderna Unusual Options Activity
Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 14 trades. If we consider the specifics of ...